Targeting ceramide synthases for the development of new antifungals
Structure · 2025
DOI: 10.1016/j.str.2025.05.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Structure, 2025. Verfasst von Deveney Dasilva und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Stony Brook University, Stony Brook, NY, USA. Hauptthemen laut MEDLINE: Antifungal Agents, Oxidoreductases, Enzyme Inhibitors, Fungal Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIAID NIH HHS, National Science Foundation.
Abstract (Originalsprache)
Invasive fungal infections (IFIs) caused by pathogenic fungi are a major public health concern, particularly across various immunocompromised populations. Effective clinical management is currently hindered by limited treatment options. Fungal sphingolipids have emerged as potential antifungal targets based on cumulative evidence demonstrating that fungal sphingolipid metabolism is key to the virulence of pathogenic fungi. This study focuses on the sphingolipid metabolizing enzyme ceramide synthase. We developed an enzymatic assay to examine ceramide synthase activity and devised a high-throughput screening platform. Two synthetic compounds were identified that preferentially inhibit the fungal vs. the mammalian ceramide synthase activity. Further studies indicate that these compounds block fungal growth, with in silico and mutagenesis investigations revealing insights into the interactions between the inhibitors and the ceramide synthase active site. Together, our study establishes fungal ceramide synthase as a promising antifungal target and paves the way for new structure-activity relationship studies leveraging fungal sphingolipid metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Stony Brook University, Stony Brook, NY, USA.
- Department of Chemistry, Stony Brook University, Stony Brook, NY, USA.
- Department of Biochemistry and Molecular Biology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA; Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA, USA.
- Department of Medicine, Stony Brook University, Stony Brook, NY, USA; Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, USA; Veterans Affairs Medical Center, Northport, NY, USA.
- Department of Chemistry, Stony Brook University, Stony Brook, NY, USA; Institute of Chemical Biology and Drug Discovery, Stony Brook University, Stony Brook, NY, USA.
- MicroRid Technologies Inc., Dix Hills, NY, USA.
Förderung
- BLRD VA
- NIAID NIH HHS
- National Science Foundation
- US Department of Defense
- National Institutes of Health
- U.S. Department of Veterans Affairs
- NIAID
- Stony Brook University
Zitieren
APA
Dasilva, D., Pereira de Sa, N., Takemura, K., Jayanetti, K., You, J. K., Vieira de Sa, N., Matos, G. S., Zhong, A., Senkal, C. E., Hannun, Y., Ojima, I., Mallamo, J., McCarthy, J. B., & Del Poeta, M. (2025). Targeting ceramide synthases for the development of new antifungals. Structure. https://doi.org/10.1016/j.str.2025.05.016
Vancouver
Dasilva D, Pereira de Sa N, Takemura K, Jayanetti K, You JK, Vieira de Sa N, et al. Targeting ceramide synthases for the development of new antifungals. Structure. 2025. doi:10.1016/j.str.2025.05.016
BibTeX
@article{Dasilva2025,
author = {Dasilva, Deveney and Pereira de Sa, Nivea and Takemura, Kathryn and Jayanetti, Kalani and You, Jeehyun Karen and Vieira de Sa, Nathalia and Matos, Gabriel Soares and Zhong, Andy and Senkal, Can E and Hannun, Yusuf and Ojima, Iwao and Mallamo, John and McCarthy, John B and Del Poeta, Maurizio},
title = {Targeting ceramide synthases for the development of new antifungals},
journal = {Structure},
year = {2025},
doi = {10.1016/j.str.2025.05.016}
}
EUVIMED